Skip to main content

Table 4 Multiple regression analysis of the relationship between MMP2 and lung cancer

From: Correlation between MMP2 expression in lung cancer tissues and clinical parameters: a retrospective clinical analysis

Variables (X) Categories (different groups) P value OR value 95% CI for OR
lower upper
Gender (X1) Male (X1–0) vs. female (X1–1) 0.154 0.532 0.223 1.267
Age (X2) < 60 (X2–0) vs. ≥60 (X2–1) 0.618 0.808 0.422 1.671
Smoking (X3) No (X3–0) vs. Yes (X32) 0.558 0.810 1.401 1.637
Histology (X4) LAC (X4–0) vs. LSCC (X41) vs. SCLC (X42) 0.300 0.702 0.360 1.370
Differentiation (X5) Poor (X5–0) vs. moderate (X5–1) vs. well (X5–2) 0.633 0.620 0.704 1.781
Lymphatic invasion (X6) N0-N1(X6–0) vs. N2-N3 (X6–1) 0.540 0.485 0.048 4.919
T stage (X7) T1-T2 (X7–0) vs. T3-T4 (X7–1) 0.307 0.648 0.139 12.32
TNM (X8) IIA - IIIA (X8–0) vs. IIIB - IV (X8–1) 0.003 2.01 2.013 3.078
MMP2 (X9) Low (X9–0) vs. moderate (X9–1) vs. high (X9–2) 0.006 1.49 1.012 2.876
Risk function: H(t) = [h0(t)] e (2.01 X8 + 1.49X9)
  1. LAC lung adenocarcinoma, LSCC lung squamous cell carcinoma, SCLC small cell lung cancer, TNM clinical stage of lung cancer, OR odds ratio, MMP2 matrix metalloproteinase 2, CI confidence interval